Contents

SynopsisCodesLook ForDiagnostic PearlsDifferential Diagnosis & PitfallsBest TestsManagement PearlsTherapyReferences

Information for Patients

View all Images (26)

Lyme disease in Child
See also in: Cellulitis DDx
Other Resources UpToDate PubMed

Lyme disease in Child

See also in: Cellulitis DDx
Contributors: Andrew Walls MD, Craig N. Burkhart MD, Dean Morrell MD, Paritosh Prasad MD, Susan Burgin MD
Other Resources UpToDate PubMed

Synopsis

Lyme disease, with cutaneous manifestations including erythema migrans, acrodermatitis chronica atrophicans (Europe), and Borrelia lymphocytoma, is an immune-mediated inflammatory disease resulting from infection with the spirochete Borrelia burgdorferi sensu lato, composed of 4 distinct genospecies: Borrelia burgdorferi sensu stricto, Borrelia garinii, Borrelia afzelii, and candidatus Borrelia mayonii. Disease usually begins with a slowly expanding skin lesion – erythema migrans (EM) – at the site of the tick bite (early localized disease).

Early disseminated disease occurs within weeks as the spirochete disseminates to the nervous system, heart, joints, and other organs. At this time, patients may develop multiple widespread skin lesions of disseminated EM along with acute neurologic abnormalities, atrioventricular (AV) block, or myocarditis.

In the United States, Lyme disease is primarily seen in New England, the Midwest states, and the west coast. It is endemic to most of Europe. The ticks that transmit Lyme disease are of the genus Ixodes (eg, Ixodes scapularis, the blacklegged tick or deer tick). Mice and deer are the major animal reservoirs. Transmission occurs most commonly in the spring and summer months. Increased risk of infection is strongly linked to the amount of time spent in wooded or rural areas.

Lyme disease has been rarely reported in China, Japan, and Russia. Although Lyme disease is not considered endemic to countries in Africa, there have been few cases of infection reported.

Rarely, coinfection with Babesia microti has been documented in adults.

Lyme disease is subdivided clinically into 3 phases:
  1. Early localized disease
  2. Early disseminated disease
  3. Late disease
Systemic Symptoms:
Systemic symptoms are seen in approximately half of patients with early localized or early disseminated disease. These symptoms are described as flu-like and include a combination of fatigue, headache, neck stiffness, myalgias / arthralgias, lymphadenopathy, or fever. With B mayonii infection, which at present seems to be limited to the upper midwestern United States, nausea and vomiting may also occur, and the rash may be more diffuse.

Stage 1 - Early Localized (days to weeks following tick bite):
  • EM at the site of the tick bite develops in approximately 60%-90% of patients.
  • In Europe, early lesions sometimes present as Borrelia lymphocytomas.
  • There may or may not be systemic symptoms.
  • False negative serological testing is common.
Stage 2 - Early Disseminated (weeks to months following tick bite):
  • Multiple widespread skin lesions represent dissemination of the infection with or without systemic symptoms.
  • Approximately 10%-15% of patients develop neurologic features including meningitis and cranial or peripheral neuropathies. Facial nerve palsy (Bell palsy) is the most commonly associated cranial nerve neuropathy. Borrelial meningoradiculitis, often called Bannwarth syndrome, is a rare manifestation (especially in Europe) associated with painful myeloradiculitis, lymphocytic meningitis, and cranial nerve palsies as well as motor weakness, headache, sleep disturbances, and sometimes gastrointestinal symptoms.
  • Approximately 5% of patients may experience cardiac manifestations, usually AV block or myocarditis.
  • Serological testing is usually positive, but false negatives may still occur.
Stage 3 - Late (months to few years):
Untreated cases can also lead to:
  • Chronic arthritis (typically knees)
  • Mild encephalopathy with subtle cognitive deficits
  • Axonal polyneuropathies
  • Acrodermatitis chronicum atrophicans (Europe)
  • Serological testing is virtually always positive.
"Chronic" Lyme Disease or Post-Lyme Disease Syndrome:
A small percentage of patients diagnosed with Lyme disease who received adequate therapeutic treatment have reported ongoing nonspecific symptoms that typically improve within one year. Persistent infections in humans despite treatment have not been reliably demonstrated. Despite extensive study of this entity, numerous expert reviews have concluded that no consistent, reproducible syndrome or evidence of persistent infection resulting in these vague symptoms exists. However, primary reinfection has been demonstrated in individuals in endemic areas.

Related topic: Lyme keratitis

Codes

ICD10CM:
A69.20 – Lyme disease, unspecified

SNOMEDCT:
23502006 – Lyme disease

Look For

Subscription Required

Diagnostic Pearls

Subscription Required

Differential Diagnosis & Pitfalls

To perform a comparison, select diagnoses from the classic differential

Subscription Required

Best Tests

Subscription Required

Management Pearls

Subscription Required

Therapy

Subscription Required

References

Subscription Required

Last Reviewed:06/25/2022
Last Updated:03/17/2024
Copyright © 2024 VisualDx®. All rights reserved.
Patient Information for Lyme disease in Child
Print E-Mail Images (26)
Contributors: Medical staff writer
Premium Feature
VisualDx Patient Handouts
Available in the Elite package
  • Improve treatment compliance
  • Reduce after-hours questions
  • Increase patient engagement and satisfaction
  • Written in clear, easy-to-understand language. No confusing jargon.
  • Available in English and Spanish
  • Print out or email directly to your patient
Copyright © 2024 VisualDx®. All rights reserved.
Lyme disease in Child
See also in: Cellulitis DDx
A medical illustration showing key findings of Lyme disease (Early Localized, B. burgdorferi) : Malaise, Tick bite, Bull's-eye, Blanching patch, Myalgia, Low grade fever
Clinical image of Lyme disease - imageId=280584. Click to open in gallery.  caption: 'A thin erythematous, annular plaque with a central thin erythematous papule.'
A thin erythematous, annular plaque with a central thin erythematous papule.
Copyright © 2024 VisualDx®. All rights reserved.